Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Current Hematologic Malignancy Reports|August 17, 2012
Biological therapy doublets: pairing rituximab with interferon, lenalidomide, and other biological agents in patients with follicular lymphomaEva KimbySeminars in Oncology|June 1, 2002
Beyond immunochemotherapy: combinations of rituximab with cytokines interferon-alpha2a and granulocyte colony stimulating factor [corrected]Eva KimbyCurrent Hematologic Malignancy Reports|April 29, 2010
Management of advanced-stage peripheral T-cell lymphomasEva KimbyEuropean Journal of Haematology|June 19, 2002
Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical courseViktoria Hjalmar, Robert Hast, Eva KimbyMedical Oncology (Northwood, London, England)|August 26, 2009
Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemiaStefan Norin, Eva Kimby, Jeanette LundinEuropean Journal of Haematology|April 20, 2004
Safety of rituximab therapy during the first trimester of pregnancy: a case historyEva Kimby, Asgerdur Sverrisdottir, Göran ElinderBritish Journal of Haematology|December 27, 2021
Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry studyLena Brandefors, Birgitta Sander, Kristina Lundqvist, et al.European Journal of Haematology|August 23, 2006
Portal vein thrombosis is a common complication following splenectomy in patients with malignant haematological diseasesMagnus Svensson, Mikael Wirén, Eva Kimby, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphomaBjörn Engelbrekt Wahlin, Birgitta Sander, Birger Christensson, et al.Pageof 12